Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

TPX-0131

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

BMS

Drug class:

ALK inhibitor

Related drugs:

ALK L1196M + ALK L1198F	Non Small Cell Lung Cancer	ALK L1196M + ALK L1198F	Non Small Cell Lung Cancer	TPX-0131 Sensitive: D – Preclinical TPX-0131 Sensitive : D	TPX-0131 Sensitive: D – Preclinical TPX-0131 Sensitive : D
ALK L1198F + ALK G1202R	Non Small Cell Lung Cancer	ALK L1198F + ALK G1202R	Non Small Cell Lung Cancer	TPX-0131 Sensitive: D – Preclinical TPX-0131 Sensitive : D	TPX-0131 Sensitive: D – Preclinical TPX-0131 Sensitive : D
ALK C1156Y + ALK G1202R	Non Small Cell Lung Cancer	ALK C1156Y + ALK G1202R	Non Small Cell Lung Cancer	TPX-0131 Sensitive: D – Preclinical TPX-0131 Sensitive : D	TPX-0131 Sensitive: D – Preclinical TPX-0131 Sensitive : D
ALK L1196M + ALK G1202R	Non Small Cell Lung Cancer	ALK L1196M + ALK G1202R	Non Small Cell Lung Cancer	TPX-0131 Sensitive: D – Preclinical TPX-0131 Sensitive : D	TPX-0131 Sensitive: D – Preclinical TPX-0131 Sensitive : D